The Drugs Controller General of India (DCGI) on Tuesday granted market authorisation to Serum Institute of India (SII) to manufacture the indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer
from Top Business News- News18.com https://ift.tt/ko80PqX
via IFTTT
Subscribe to:
Post Comments (Atom)
-
Theyve endured a financial crisis. Two deep recessions. Mounds of student debt. Stagnant pay. Costly health care. Dim job prospects. from ...
-
Krsnaa Diagnostics IPO Allotment: Investors can check the share allotment status in two ways a) via BSE b) via registrar’s website from To...
-
....क्योंकि पढ़ाई के लिए महंगी कीमत चुकानी पड़ती है... यहां के बच्चों को बाघों के इलाके में पढ़ने लिए हर... from आज तक https://ift.tt/2Ec...
No comments:
Post a Comment